Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1986 2
1991 1
1995 2
1997 1
1998 1
1999 3
2003 1
2004 1
2005 2
2006 2
2008 5
2009 3
2010 8
2011 11
2012 12
2013 11
2014 17
2015 13
2016 15
2017 8
2018 6
2019 6
2020 9
2021 12
2022 10
2023 2
2024 5
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

160 results

Results by year

Filters applied: . Clear all
Page 1
Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma.
Stewart AK, Rajkumar SV, Dimopoulos MA, Masszi T, Špička I, Oriol A, Hájek R, Rosiñol L, Siegel DS, Mihaylov GG, Goranova-Marinova V, Rajnics P, Suvorov A, Niesvizky R, Jakubowiak AJ, San-Miguel JF, Ludwig H, Wang M, Maisnar V, Minarik J, Bensinger WI, Mateos MV, Ben-Yehuda D, Kukreti V, Zojwalla N, Tonda ME, Yang X, Xing B, Moreau P, Palumbo A; ASPIRE Investigators. Stewart AK, et al. Among authors: siegel ds. N Engl J Med. 2015 Jan 8;372(2):142-52. doi: 10.1056/NEJMoa1411321. Epub 2014 Dec 6. N Engl J Med. 2015. PMID: 25482145 Free article. Clinical Trial.
Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes.
Skerget S, Penaherrera D, Chari A, Jagannath S, Siegel DS, Vij R, Orloff G, Jakubowiak A, Niesvizky R, Liles D, Berdeja J, Levy M, Wolf J, Usmani SZ; MMRF CoMMpass Network; Christofferson AW, Nasser S, Aldrich JL, Legendre C, Benard B, Miller C, Turner B, Kurdoglu A, Washington M, Yellapantula V, Adkins JR, Cuyugan L, Boateng M, Helland A, Kyman S, McDonald J, Reiman R, Stephenson K, Tassone E, Blanski A, Livermore B, Kirchhoff M, Rohrer DC, D'Agostino M, Gambella M, Collison K, Stumph J, Kidd P, Donnelly A, Zaugg B, Toone M, McBride K, DeRome M, Rogers J, Craig D, Liang WS, Gutierrez NC, Jewell SD, Carpten J, Anderson KC, Cho HJ, Auclair D, Lonial S, Keats JJ. Skerget S, et al. Among authors: siegel ds. Nat Genet. 2024 Sep;56(9):1878-1889. doi: 10.1038/s41588-024-01853-0. Epub 2024 Aug 19. Nat Genet. 2024. PMID: 39160255 Free PMC article.
Idecabtagene vicleucel for relapsed and refractory multiple myeloma: post hoc 18-month follow-up of a phase 1 trial.
Lin Y, Raje NS, Berdeja JG, Siegel DS, Jagannath S, Madduri D, Liedtke M, Rosenblatt J, Maus MV, Massaro M, Petrocca F, Yeri A, Finney O, Caia A, Yang Z, Martin N, Campbell TB, Rytlewski J, Fuller J, Hege K, Munshi NC, Kochenderfer JN. Lin Y, et al. Among authors: siegel ds. Nat Med. 2023 Sep;29(9):2286-2294. doi: 10.1038/s41591-023-02496-0. Epub 2023 Aug 17. Nat Med. 2023. PMID: 37592106 Free PMC article. Clinical Trial.
Real-world safety and efficacy of teclistamab in relapsed/refractory multiple myeloma: results from a multicenter, retrospective study and descriptive meta-analysis.
Varma G, Fogel L, Gordon B, Saldarriaga MM, Ahn J, Aleman A, Caro J, Rosenberg MC, Monge J, Parmar H, Kaminetzky D, Moskovits T, Siegel DS, Morgan GJ, Niesvizky R, Davies FE, Biran N. Varma G, et al. Among authors: siegel ds. Leuk Lymphoma. 2025 May;66(5):942-951. doi: 10.1080/10428194.2024.2446617. Epub 2025 Jan 5. Leuk Lymphoma. 2025. PMID: 39756041
Elotuzumab for the treatment of multiple myeloma.
Wang Y, Sanchez L, Siegel DS, Wang ML. Wang Y, et al. Among authors: siegel ds. J Hematol Oncol. 2016 Jul 15;9(1):55. doi: 10.1186/s13045-016-0284-z. J Hematol Oncol. 2016. PMID: 27417553 Free PMC article. Review.
A phase IIb study of selinexor in combination with daratumumab in patients with daratumumab-refractory multiple myeloma.
Biran N, Zolotov E, Vesole D, Parmar H, Phull P, Doucette K, Roney P, Ahn J, Feinman R, Zenreich J, Anand P, Pace M, Pia AD, DeAgresta B, Biamonte L, Aleman A, Rutanen E, Chappell A, Kumka S, Siegel DS. Biran N, et al. Among authors: siegel ds. Haematologica. 2025 Oct 1;110(10):2493-2497. doi: 10.3324/haematol.2024.287053. Epub 2025 Apr 3. Haematologica. 2025. PMID: 40176757 Free PMC article. No abstract available.
Oral dosing of the nucleoside analog obeldesivir is efficacious against RSV infection in African green monkeys.
Pitts J, Zamora JLR, Manhas S, Aeschbacher T, Chan J, Cutillas V, Nair V, Riola NC, Vijjapurapu A, Vermillion MS, Eng S, Richards C, Han D, Perry JK, Chaudhuri S, Liu SW, Martinez C, Peinovich N, Sun KH, Cai A, Martin R, Moshiri J, Hedskog C, Babusis D, Siegel DS, Kalla R, Avadhanula V, Piedra PA, Stobbelaar K, Delputte PL, Marceau C, Mateo R, Maiorova E, Mo H, Subramanian R, Mackman RL, Cihlar T, Fletcher SP, Bilello JP. Pitts J, et al. Among authors: siegel ds. Nat Commun. 2025 Jul 11;16(1):6437. doi: 10.1038/s41467-025-61595-3. Nat Commun. 2025. PMID: 40645925 Free PMC article.
160 results